Suzano (NYSE: SUZ) sets R$2.5B rural notes issue for forestry
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Suzano S.A. approved the second issuance of up to 2,500,000 financial liquidation rural product notes (CPR-Fs), each with a unit value of R$1,000.00, totaling R$2,500,000,000.00. These book-entry securities will be publicly distributed to professional investors in up to two series.
The first series may include a maximum of 1,500,000 CPR-Fs, equivalent to R$1,500,000,000.00, and the second series at least 1,000,000 CPR-Fs, equivalent to R$1,000,000,000.00, with allocation defined via a communicating-vessels system during a bookbuilding procedure.
The net funds raised will be used to form and exploit homogeneous forests and to conserve native forests. Completion of the offering and payment for the CPR-Fs depends on market conditions and compliance with contractual, regulatory, and legal requirements.
Positive
- None.
Negative
- None.
Insights
Suzano structures a R$2.5B rural notes deal earmarked for forestry projects.
Suzano plans to issue CPR-Fs totaling R$2,500,000,000.00, split between two series using a bookbuilding process with professional investors under Brazilian CVM rules. This diversifies its funding through rural product notes, a structure linked to agribusiness and forestry activities.
The company states that net proceeds will finance homogeneous forest formation and exploitation and conservation of native forests, tying the funding directly to core operations with an environmental dimension. Actual issuance volume per series will depend on investor demand identified in the bookbuilding.
Completion of the offering is explicitly conditioned on market conditions and regulatory and contractual compliance, so the timing and final allocation between series remain open. Further company and CVM website postings are expected to detail execution progress as the CPR-Fs Offering advances.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March, 2026.
Commission File Number 001-38755
Suzano S.A.
(Exact name of registrant as specified in its charter)
(Exact name of registrant as specified in its charter)
SUZANO INC.
(Translation of Registrant’s Name into English)
(Translation of Registrant’s Name into English)
Av. Professor Magalhaes Neto, 1,752
10th Floor, Rooms 1010 and 1011
Salvador, Brazil 41 810-012
(Address of principal executive office)
10th Floor, Rooms 1010 and 1011
Salvador, Brazil 41 810-012
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☑ Form 40-F ☐
Form 20-F ☑ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Enclosures:
Exhibit 99.1 – Second issuance of financial liquidation rural product notes
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: March 09th, 2026
SUZANO S.A. | ||||||||
| By: | /s/ Marcos Moreno Chagas Assumpção | |||||||
| Name: | Marcos Moreno Chagas Assumpção | |||||||
| Title: | Vice-President of Finance and Investor Relations | |||||||
NOTICE TO THE MARKET
SUZANO S.A.
Publicly Held Company with Authorized Capital
CNPJ/MF No. 16.404.287/0001-55
NIRE 29.300.016.331
São Paulo, March 09, 2026 - Suzano S.A. ("Suzano" or "Company") (B3: SUZB3 | NYSE: SUZ) hereby informs its shareholders and the market, in compliance with the provisions of article 157, paragraph 4, of Law No. 6. 404, December 15, 1976, as amended ("Brazilian Corporate Law"), that, at a meeting of the Company's Board of Directors held on March 05, 2026 ("BoD Meeting”), the 2nd (second) issuance of 2,500,000 (two million and five hundred) financial liquidation rural product notes, book-entry, in up to two series (“CPR-Fs” and "Issuance of CPR-Fs"), with a unit value of R$1,000.00 (one thousand reais) each, on the date of their respective issue, in the total amount of R$2,500,000,000.00 (two billion and five hundred million reais) of which will be issued (i) a maximum of 1,500,000 (one million and five hundred thousand) first series CPR-Fs, equivalent to R$ 1,500,000,000.00 (one billion and five hundred million reais) ("Maximum Volume of the First Series CPR-Fs"); and (ii) at least 1,000,000 (one million) second series CPR-Fs, equivalent to R$ 1,000,000,000.00 (one billion reais) ("Minimum Volume of the Second Series CPR-Fs"), noting that the allocation of CPR-Fs between the series should occur according to the system of communicating vessels (“System of Communicating Vessels”) which shall be intended for the Professional Investors, as referred to in the Articles 11 and 13 of CVM Resolution No. 30, dated May 11, 2021, pursuant to CVM Resolution No. 160, dated July 13, 2022, as amended (“CVM Resolution 160”), as currently in force, and whose issuer qualifies as an EGEM and, consequently, an EFRF (“CPR-Fs Offering”).
The CPR-Fs to be issued by the Company will be subject to public distribution, with the CPR-Fs Offering being subject to the automatic rite of registration of a public offering for the distribution of securities, without the need for prior analysis by the CVM, by means of the automatic distribution registration rite, under the terms of article 25, 26, item IV, paragraph (a) of CVM Resolution 160, noting that the Company qualifies as a Large Market Exposure Issuer, and consequently as a Frequent Issuer of Fixed Income Securities, under the terms of articles 38 and 38-A of CVM Resolution No. 80, of March 29, 2022, as amended.
The procedure for collecting investment intentions will be adopted, with receipt of reserves from investors, without minimum or maximum lots, to be conducted by the underwriters of the CPR-s Offering, pursuant to articles 61 and 62 of CVM Resolution 160, as well as under the terms of the distribution agreement, subject to the provisions of article 61, paragraphs 2 and 3, of CVM Resolution 160, through which the underwriters will verify the market demand for the CPR-Fs, for verification and definition, together with the Company, the amount of CPR-Fs to be allocated in each series of the
Issuance of CPR-Fs, according to the Communicating Vessel System and observing the Maximum Volume of the First Series CPR-Fs and the Minimum Volume of the Second Series CPR-Fs ("Bookbuilding Procedure").
The net funds raised by the Company through the Issuance of CPR-Fs will be used for the formation and exploitation of homogeneous forests, as well as the conservation of native forests.
Notwithstanding the approval within the scope of the BoD Meeting, it should be noted that the completion of the CPR-Fs Offering and, consequently, the payment of the CPR-Fs, is subject, among other factors, to market conditions and compliance with the applicable contractual, regulatory and normative requirements.
The minute of the Meeting of the Company's Board of Directors that approved the terms and conditions of the CPR-Fs and the Issuance of CPR-Fs, are available for consultation on the Company's website (https://ri.suzano.com.br/Portuguese/Arquivamentos/Documentos-entregues-a-CVM/default.aspx) and on the CVM website (www.cvm.gov.br).
The Company will keep its shareholders and the market informed about the development of the Issuance of CPR-Fs and the CPR-Fs Offering, as well as any new relevant developments linked to the Issuance of CPR-Fs. This notice to the market is for information purposes only, under the terms of the regulations in force, and does not constitute and should not be interpreted as any effort to sell the CPR-Fs.
Finally, Suzano reiterates its commitment to financial discipline and transparency with its investors.
São Paulo, March 09, 2026.
Vice-President of Finance and Investor RelationsFAQ
What financing did Suzano (SUZ) approve in its March 2026 Form 6-K?
Suzano approved the second issuance of 2,500,000 financial liquidation rural product notes (CPR-Fs), each at R$1,000.00, totaling R$2.5 billion. The notes will be publicly distributed to professional investors in Brazil under CVM Resolution 160 and related rules.
How are Suzano (SUZ) CPR-Fs split between the two series in this issuance?
Suzano plans a maximum of 1,500,000 first-series CPR-Fs, equivalent to R$1.5 billion, and at least 1,000,000 second-series CPR-Fs, equivalent to R$1.0 billion. Final allocation between the series will follow a communicating-vessels system defined during the bookbuilding procedure.
Who can invest in Suzano (SUZ) R$2.5 billion CPR-Fs offering?
The CPR-Fs are intended for Professional Investors as defined in Articles 11 and 13 of CVM Resolution No. 30 and offered under CVM Resolution 160. Underwriters will collect investment intentions from these investors through a bookbuilding procedure without minimum or maximum lot sizes.
What will Suzano (SUZ) use the CPR-Fs proceeds for?
Suzano states that net funds from the CPR-Fs issuance will finance the formation and exploitation of homogeneous forests and the conservation of native forests. This links the R$2.5 billion funding directly to the company’s forestry operations and environmental conservation initiatives.
What conditions affect completion of Suzano (SUZ) CPR-Fs offering?
Completion of the CPR-Fs offering and payment for the notes depends on market conditions and compliance with applicable contractual, regulatory and normative requirements. The company emphasizes that the notice is informational only and not a sales effort for the CPR-Fs.
Where can investors find detailed documentation on Suzano (SUZ) CPR-Fs issuance?
The minutes of the Board of Directors meeting that approved the CPR-Fs terms are available on Suzano’s investor relations website and on the CVM website. These documents outline detailed conditions for the issuance and the public distribution of the CPR-Fs.